CHASE THERAPEUTICS

An innovative specialty pharmaceutical company advancing superior treatments for brain disease.

Add To Watchlist
General Information
Company Name
CHASE THERAPEUTICS
Founded Year
2017
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
2
Industries
Health and Wellness, Medical Devices, Pharmaceutical
Funding Stage
Series B
Social Media

CHASE THERAPEUTICS - Company Profile

Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company established in 2017. The company is dedicated to advancing superior treatments for brain disease, operating within the Health and Wellness, Medical Devices, and Pharmaceutical industries. In October 2021, Chase Therapeutics secured a significant $20.00M Series B investment from Brain Trust Accelerator Fund and China Link Capital.

Taxonomy: specialty pharmaceuticals, brain disease, treatment development, early-stage, product-based, neurology, pharmaceutical company, medical innovation

Funding Rounds & Investors of CHASE THERAPEUTICS (4)

View All
Funding Stage Amount No. Investors Investors Date
Series B $20.00M 2
Brain Trust Accelerator Fund, investor in CHASE THERAPEUTICS's Series B round China Link Capital, investor in CHASE THERAPEUTICS's Series B round
20 Oct 2021
Venture Round Unknown 2
Revolution, investor in CHASE THERAPEUTICS's Venture Round round
Revolution’s Rise of the Rest Seed Fund 		29 Oct 2019
Series A $4.00M - 28 Aug 2018
Series A $1.30M - 21 Nov 2017

Latest News of CHASE THERAPEUTICS

View All

No recent news or press coverage available for CHASE THERAPEUTICS.

Similar Companies to CHASE THERAPEUTICS

View All

No funding or investment information available for CHASE THERAPEUTICS at this time.

Circle Decoration Circle Decoration

Want to dive deeper into CHASE THERAPEUTICS? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now